Authors: BUZELIN JM ROTH S GEFFRIAUDRICOUARD C DELAUCHECAVALLIER MC COULANGE C DELMAS V JACQUMIN D JUNG JL HODE E TENAILLON M TOUBOL J DELAERE PJ CORBUSIER A DJURHUNS JC NERSTROM B HERZIG J HENKE G GROTHUESMAN H WEGE B KUTSCHER KR KOCHS K TIETZE M ALBRECHT J SCHONHERR G QUAST D VARDAKIS G PREISS H BASSIRI AM KUHN E PILASKI K WINKLER WP KNUPFER E WULSCH E MATZ HJ WULFF HJ WITTKOWSKY K SCHUTT W SIMON J BOHM G COORS H WIDJAJA F SIEGMUND H SCHMIDT JM KRAUSE U ENGELS KG BRICKENKAMP A HEISING J SCHAEFER RM NELLES P

Citation: Jm. Buzelin et al., EFFICACY AND SAFETY OF SUSTAINED-RELEASE ALFUZOSIN 5 MG IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA, European urology, 31(2), 1997, pp. 190-198

Authors: JANSSEN T PETEIN M VANVELTHOVEN R DEDECKER R ASSENMACHER C CORBUSIER A PASTEELS JL KISS R SCHULMAN C

Citation: T. Janssen et al., COREGULATORY EFFECTS OF EPIDERMAL GROWTH-FACTOR, DIHYDROTESTOSTERONE,AND PROLACTIN ON BENIGN HUMAN PROSTATIC HYPERPLASIA TISSUE-CULTURE PROLIFERATION, The Prostate, 30(1), 1997, pp. 47-52

Authors: SCHULMAN CC CORBUSIER A MICHIELS H TAENZER HJ

Citation: Cc. Schulman et al., ORAL IMMUNOTHERAPY OF RECURRENT URINARY-TRACT INFECTIONS - A DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY - REPLY, The Journal of urology, 152(1), 1994, pp. 173-174

Authors: SCHULMAN CC CORBUSIER A MICHIELS H TAENZER HJ

Citation: Cc. Schulman et al., ORAL IMMUNOTHERAPY OF RECURRENT URINARY-TRACT INFECTIONS - A DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY, The Journal of urology, 150(3), 1993, pp. 917-921